NCT05858034 Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and Older
| NCT ID | NCT05858034 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wake Forest University Health Sciences |
| Condition | HIV |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-06-27 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-06-27 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective of this study is to identify and characterize frailty and pre-frailty in persons age 50 and older living with human immunodeficiency virus (HIV) followed by the Atrium Health Wake Forest Baptist Infectious Diseases Specialty Clinics (IDSC).
Eligibility Criteria
Inclusion Criteria: * Person living with human immunodeficiency virus (HIV) * Age ≥50 years * Followed by the Atrium Health Wake Forest Baptist Infectious Diseases Specialty Clinic (IDSC) * Eligible for Ryan White Program * Able to provide informed consent * Pre-frail or frail by electronic frailty index (eFI) Exclusion Criteria: * Age \<50 years (study designed to characterize frailty in aging persons with HIV) * Unable to complete the required assessments or questionnaires
Contact & Investigator
Caryn G Morse, MD, MPH
PRINCIPAL INVESTIGATOR
Wake Forest University Health Sciences
Frequently Asked Questions
Who can join the NCT05858034 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05858034 currently recruiting?
Yes, NCT05858034 is actively recruiting participants. Contact the research team at yolanda.belin@advocatehealth.org for enrollment information.
Where is the NCT05858034 trial being conducted?
This trial is being conducted at Winston-Salem, United States.
Who is sponsoring the NCT05858034 clinical trial?
NCT05858034 is sponsored by Wake Forest University Health Sciences. The principal investigator is Caryn G Morse, MD, MPH at Wake Forest University Health Sciences. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.